Inventor
Martin Stogniew
Inventor
Blue Bell, PA, US
Overview
Patents· 40 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes38%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
C07DHeterocyclic compounds13%
Y02ATechnologies for adaptation to climate change5%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms4%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
A61CDentistry2%
C07KPeptides2%
C07CAcyclic or carbocyclic compounds1%
C07HSugars1%
PatentTitleYear
11,116,771G protein-coupled receptor (GPCR) modulation by imipridones202110,953,0147-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-A]pyrido[3,4-E]pyrimidin-5 (1H)-one, salts thereof and methods of using the same in combination therapy202110,946,022Imipridones for gliomas202110,456,4027-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-A]pyrido[3,4-E]pyrimidin-5 (1H)-one, salts thereof and methods of using the same in combination therapy201910,369,154Imipridones for gliomas201910,266,5337-Benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo [1,2-A]pyrido[3,4-E]pyrimidin-5(1H)-one, analogs thereof, and salts thereof and methods for their use in therapy201910,172,862Imipridones for gliomas201910,045,9927-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5 (1h)-one, salts thereof and methods of using the same in combination therapy20189,845,3247-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo [1,2-A]pyrido[3,4-E]pyrimidin-5(1H)-one, analogs thereof, and salts thereof and methods for their use in therapy20179,688,679'7-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-A]pyrido[3,4-E]pyrimidin-5 (1H)-one, salts thereof and methods of using the same in combination therapy'20179,376,437'7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one, salts thereof and methods of using the same in combination therapy'20169,265,765'7-benzyl-10-(2-methylbenzyl)-2,6,7,8,9,10-hexahydroimidazo[1,2-A]pyrido[4,3-D]pyrimidin-5(3H)-one, salts thereof and methods of using the same in combination therapy'20168,501,818'Stabilized compositions of alkylating agents and methods of using same'20138,143,212'Dalbavancin compositions for treatment of bacterial infections'20127,629,333'Stable amorphous amifostine compositions and methods for the preparation and use of same'20097,198,796'Antifungal parenteral products'20077,151,094'Topical administration of amifostine and related compounds'20067,119,061'Dalbavancin compositions for treatment of bacterial infections'20067,115,564'Stable pharmaceutical compositions of dalbavancin and methods of administration'20067,105,575'Methods for the treatment of neuro- disorders using aminothiol compounds'20066,991,800'Antifungal parenteral products'20066,900,175'Methods of administering dalbavancin for treatment of bacterial infections'20056,841,545'Stable amorphous amifostine compositions and methods for the preparation of same'20056,814,987'Compositions and methods of use for extracts of magnoliaceae plants'20046,753,323'Topical administration of amifostine and related compounds'20046,586,476'Methods for the treatment of nephro-disorders using aminothiol compounds'20036,582,735'Compositions and methods of use for extracts of magnoliaceae plants'20036,576,635'Compositions comprising trimetrexate'20036,573,253'Methods for the administration of amifostine and related compounds'20036,489,312'Pharmaceutical formulations comprising aminoalkyl phosphorothioates'20026,407,278'Stable amorphous amifostine compositions and methods for the preparation and use of the same'20026,384,259'Stable amorphous amifostine compositions and dosage form'20026,258,821'Compositions comprising trimetrexate and methods of their synthesis and use'20016,258,952'Thermally stable trimetrexates and processes for producing the same'20016,239,119'Topical administration of amifostine and related compounds'20016,218,377'Methods for the administration of amifostine and related compounds'20016,127,351'Method for the administration of amifostine and related compounds'20006,051,563'Methods for the administration of amifostine and related compounds'20006,017,922'Thermally stable trimetrexates and processes for producing the same'20005,994,409'Methods for treatment of neuro--and nephro--disorders and therapeutic toxicities using aminothiol compounds'1999Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1999–2000Patents assigned to US BIOSCIENCE (3)· patent assignee history
1999–2019Based in Blue Bell, PA, US· patent location history
2000–2006Patents assigned to MEDIMMUNE ONCOLOGY INC (14)· patent assignee history
2005–2012Patents assigned to VICURON PHARM INC (6)· patent assignee history
2016–2021Patents assigned to ONCOCEUTICS INC (12)· patent assignee history
2016–2021Based in Blue Pell, PA, US· patent location history
2017–2019Patents assigned to PROVID PHARMACEUTICALS INC (3)· patent assignee history
2021Based in Lakewood Ranch, FL, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MEDIMMUNE ONCOLOGY INC | 14 | 2000–2006 |
| ONCOCEUTICS INC | 12 | 2016–2021 |
| VICURON PHARM INC | 6 | 2005–2012 |
| PROVID PHARMACEUTICALS INC | 3 | 2017–2019 |
| US BIOSCIENCE | 3 | 1999–2000 |
Locations
| Location | Patents | Span |
|---|---|---|
| Blue Bell, Pennsylvania, US | 31 | 1999–2019 |
| Blue Pell, Pennsylvania, US | 7 | 2016–2021 |
| Lakewood Ranch, Florida, US | 2 | 2021 |